Helus Pharma Reports Fiscal Year 2026 Results and Business Highlights
Helus Pharma announced its audited financial results for the fiscal year ended March 31, 2026, along with recent business highlights. The company recently closed a $50 million underwritten offering, which reinforces institutional investor conviction and strengthens its balance sheet for the…